Title:
HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19
Document Type and Number:
WIPO Patent Application WO/2021/173713
Kind Code:
A8
Abstract:
The present invention is the use of purine nucleotide phosphoramidates or pharmaceutically acceptable salts thereof administered in an effective amount for the treatment or prevention of COVID-19, an infection caused by the SARS CoV-2 virus in a host, for example a human, in need thereof.
Inventors:
SOMMADOSSI JEAN-PIERRE (US)
MOUSSA ADEL (US)
MOUSSA ADEL (US)
Application Number:
PCT/US2021/019468
Publication Date:
October 07, 2021
Filing Date:
February 24, 2021
Export Citation:
Assignee:
ATEA PHARMACEUTICALS INC (US)
International Classes:
A61K31/7076; A61P31/14; C07H19/207
Attorney, Agent or Firm:
BELLOWS, Brent, R. (US)
Download PDF: